Acacia Research Corp., of Newport Beach, Calif., appointed Dindyal Ramkissoon vice president of sales and marketing of its CombiMatrix group's subsidiary, Combimatrix Molecular Diagnostics Inc.

Arius Research Inc., of Toronto, appointed Joseph Zakrzewski to its board.

BioReliance Corp., of Rockville, Md., appointed David Onions chief scientific officer.

CellCyte Genetics Corp., of Kirkland, Wash., appointed Andreas Kalmes vice president of pharmacology.

Compugen Ltd., of Tel Aviv, Israel, appointed Ronit Lerner chief financial officer and Rachel Bart general counsel.

Cytori Therapeutics Inc., of San Diego, appointed director Ronald Henriksen to serve as interim chairman.

DiaDexus Inc., of South San Francisco, appointed David Foster chief financial officer and executive vice president, and Dino Alfano executive vice president, sales and marketing. DiaDexus also appointed Charles Patrick to its board.

IDM Pharma Inc., of Irvine, Calif., hired Robert De Vaere as senior vice president and chief financial officer.

Ilypsa Inc., of Santa Clara, Calif., promoted Paul Stone to senior vice president, general counsel and chief patent counsel.

ImmuneRegen BioSciences Inc., of Scottsdale, Ariz., appointed Frederick Burkle Jr. to its bioterrorism/pandemic influenza advisory board.

Innovive Pharmaceuticals Inc., of New York, appointed Philip Frost to its board.

La Jolla Pharmaceutical Co., of San Diego, hired Peter Potgieter as vice president and medical director.

Medicure Inc., of Winnipeg, Manitoba, appointed Bonnie Zell senior adviser of commercial operations.

Metabolex Inc., of Hayward, Calif., hired Bonnie Charpentier as vice president, regulatory affairs.

NicOx SA, of Sophia Antipolis, France, hired Sanjiv Sharma as vice president of commercial affairs.

Penwest Pharmaceuticals Co., of Danbury, Conn., hired Amale Hawi as senior vice president, pharmaceutical development.

PhotoMedex Inc., of Montgomeryville, Pa., appointed Stephen Connelly to its board.

PrimeGen Biotech LLC, of Irvine, Calif., appointed Rudolf Jaenisch to its scientific advisory board.

PTC Therapeutics Inc., of South Plainfield, N.J., promoted Neil Almstead to senior vice president of chemistry and CMC, or chemistry manufacturing and controls.

QLT Inc., of Vancouver, British Columbia, said David Saperstein will join the company as a consultant and interim chief medical officer, and Paul Kaufman as head of its ocular scientific advisory board.

Rosetta Genomics Ltd., of Rehovot, Israel, appointed J. Michael French as president of its U.S. subsidiary, Rosetta Genomics Inc.

SinoBiomed Inc., of Shanghai, China, said Dicken Shiu-Chung Ko joined its advisory board.

Sloning Biotechnology, of Puchheim, Germany, appointed Thomas Matthes chief business officer.

Techne Corp., of Minneapolis, appointed Richard Krzyzek vice president of research for its biotechnology division.

Tengion Inc., of East Norriton, Pa., hired Sharon Presnell as vice president for regenerative medicine and biology.

Upstream Biosciences Inc., of Vancouver, British Columbia, appointed Dale Pfost to its board.

ViRexx Medical Corp., of Edmonton, Alberta, hired Gary Woerz as chief financial officer.

Viron Therapeutics Inc., of London, Ontario; and Boston, appointed Claude Benedict senior vice president, clinical development and regulatory affairs.

No Comments